Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.
Shaheen M, Hassanain M, Aljiffry M, Cabrera T, Chaudhury P, Simoneau E, Kongkaewpaisarn N, Salman A, Rivera J, Jamal M, Lisbona R, Khankan A, Valenti D, Metrakos P.
Shaheen M, et al.
HPB (Oxford). 2012 Jan;14(1):60-6. doi: 10.1111/j.1477-2574.2011.00405.x. Epub 2011 Nov 14.
HPB (Oxford). 2012.
PMID: 22151453
Free PMC article.